Ines joined the Mtech Access team in August 2020 as a senior consultant in the Global Market Access Team after a rich experience at another pharmaceutical consulting firm. Ines has overseen and contributed across a variety of pricing and market access projects working with a range of clients from large global pharmaceutical companies. Her experience includes global pricing and market access strategy, HTA strategic insights, value story testing, evidence development strategy, and market access landscape research across a wide range of markets (including EU5, USA, China, Japan, Canada, and other European and Emerging Markets). Ines’ keen interest and focus is in rare diseases and oncology, but her experience also spans therapy areas including diabetes, neurology, respiratory, cardiovascular, and oncology in vitro diagnostics. Ines was awarded a PhD by the University of Porto, Portugal for her research in paediatric cancers at the Massachusetts General Hospital/Harvard Medical School in Boston, USA, and has a first-class MSc and BSc In Molecular Biology and Genetics from the University of Lisbon, Portugal.